COVID19

Changes in Smoking Cessation–Related Behaviors Among US Adults During the COVID-19 Pandemic

Scientific article

Key Points Question Did smoking cessation–related behaviours change during the COVID-19 pandemic in the US? Findings This cross-sectional study among 788 008 US adult smokers found that the annual prevalence of past-year quit attempts...

Impact of Comorbid COVID-19 and Substance Use During Pregnancy on Fetal and Infant Development Workshop

20 July 2022

Online

Wednesday, July 20, 2022 10:00am to 5:00pm

NIDA Brain Development Research Consortium

Numerous underlying medical conditions are associated with worse outcomes for those infected with SARS-CoV-2, including pregnancy and recent pregnancy (defined as at least 42 days following the end of pregnancy).

Association of Psychiatric Disorders With Incidence of SARS-CoV-2 Breakthrough Infection Among Vaccinated Adults

Scientific article

14 April 2022

Abstract Importance Psychiatric disorders may be associated with an increased risk for SARS-CoV-2 breakthrough infection after vaccination, but no studies have tested this hypothesis. Objective To evaluate whether past diagnoses of...

Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic

Scientific article

18 March 2022

Background The long-running opioid epidemic and the more recent COVID-19 pandemic are two interrelated events with major public health implications for people who use opioids (OUD). The majority of studies on the interaction of these two...

COVID 19—impact on substance use treatment utilisation and provision in South Africa

Scientific article

3 March 2022

Background The coronavirus disease 2019 (COVID-19) pandemic has affected persons suffering from substance use disorders (SUDs) all around the world. The purpose of this study was to investigate changes in the number of SUD treatment...

Join us at the COMMISSION ON NARCOTIC DRUGS this week!

News

Dear friends and colleagues, The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022. Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good thing...

Mujeres, consumo de alcohol y la pandemia de COVID-19

15 March 2022

Washington DC

United States

La Organización Panamericana de la Salud (OPS), invita a participar este martes, 15 de marzo, en el seminario virtual "Mujeres, consumo de alcohol y la pandemia de COVID-19". Se abordará el impacto de la pandemia de COVID-19 sobre la salud mental de las mujeres, el consumo de alcohol y cómo la comercialización del alcohol, las políticas y las intervenciones han influido sobre la salud de las mujeres durante la pandemia de COVID-19.

Daily cannabis use during the novel coronavirus disease (COVID-19) pandemic in Canada: a repeated cross-sectional study from May 2020 to December 2020

Scientific article

21 February 2022

The novel coronavirus disease (COVID-19) pandemic has resulted in substantial burden of disease in Canada. Daily cannabis use is most strongly implicated in the cannabis-attributable burden of disease. In the context of the novel...

Consequences of Lockdown and the COVID-19 Pandemic for a Selected Sport – Comparative Study

Scientific article

21 September 2021

BACKGROUND In December 2019, severe viral pneumonia caused by the new beta coronavirus appeared in China. It spread rapidly around the world and affected it greatly. In order to stop the global COVID-19 pandemic, the world was forced to...

Preference and Behaviour Change Regarding Selected Performance-Enhancing Anabolic Androgenic Substances and Steroids in the Context of the Global COVID-19 Pandemic

Scientific article

4 September 2021

BACKGROUND: In December 2019, the Chinese government reported patients with viral pneumonia caused by a new beta coronavirus in Wuhan. In a very short time, the virus spread around the world, causing a global pandemic referred to as COVID...